Admission Date:  [**2110-5-20**]              Discharge Date:   [**2110-5-25**]  Date of Birth:  [**2040-3-22**]             Sex:   F  Service: SURGERY  Allergies: Compazine / Sulfa (Sulfonamide Antibiotics) / Penicillins / aspirin / hydrochlorothiazide  Attending:[**First Name3 (LF) 695**] Chief Complaint: Hepatocellular carcinoma.
Past Medical History: PMH: hypertrophic obstructive cardiomyopathy, ERCP [**2102**] for elevated lipase and amylase that was normal, colonoscopy [**2100**] normal, HTN, GERD, HLD, RA PSH: appendectomy [**2059-5-7**]   Social History: Married with children (many of whom are in medicine).
Physical Exam: PE on discharge: VS: T 99, HR 87, BP 118/60, RR 18, 95% RA CV: RRR, no murmurs, rubs or gallops Pulm: CTA bilaterally Abd: Incision clean/dry/intact without erythema or drainage; abdomen soft, nontender, with +Bowel Sounds throughout Ext: Symmetric peripheral 2+ pulses throughout, with minimal edema in lower extremities   Pertinent Results: Laboratory: [**2110-5-19**] 08:15AM BLOOD WBC-6.9 RBC-3.97* Hgb-11.8* Hct-35.2* MCV-89 MCH-29.8 MCHC-33.6 RDW-12.6 Plt Ct-376 [**2110-5-20**] 03:53PM BLOOD WBC-15.2*# RBC-2.76*# Hgb-8.3*# Hct-24.2* MCV-88 MCH-30.0 MCHC-34.2 RDW-12.6 Plt Ct-329 [**2110-5-23**] 08:50AM BLOOD WBC-16.7* RBC-3.62* Hgb-10.8* Hct-31.4* MCV-87 MCH-29.9 MCHC-34.5 RDW-13.9 Plt Ct-239 [**2110-5-21**] 09:50AM BLOOD PT-13.6* PTT-31.8 INR(PT)-1.2* [**2110-5-23**] 08:50AM BLOOD Glucose-90 UreaN-8 Creat-0.7 Na-133 K-3.8 Cl-99 HCO3-24 AnGap-14 [**2110-5-19**] 08:15AM BLOOD ALT-17 AST-29 AlkPhos-108* TotBili-0.6 [**2110-5-23**] 08:50AM BLOOD ALT-106* AST-74* AlkPhos-91 TotBili-1.1 [**2110-5-23**] 08:50AM BLOOD Albumin-3.0* Calcium-8.4 Phos-1.9* Mg-2.0  Brief Hospital Course: The patient was admitted to the West 1 Surgical Service for an elective segment V mass resection with intraoperative ultrasound, on [**2110-5-20**].
After a brief, uneventful stay in the PACU, the patient arrived on the floor NPO, on IV fluids, with a foley catheter, and IV pain control.
Neuro: The patient received IV analgesiscs with good effect and adequate pain control.
When tolerating oral intake, the patient was transitioned to oral pain medications, Dilaudid.
She spiked a low grade fever to 100.9 on POD 3 with a non-productive cough and CXR showed evidence of atelectasis; she remained afebrile throughout the rest of her stay, frequently using incenstive spirometry.
GI/GU/FEN: Post-operatively, the patient was made NPO with IV fluids.
Prophylaxis: The patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible, and was cleared by physical therapy to return home.
Medications on Admission: Diltiazem 360 mg qd, Ethacrynic acid 12.5 mg qd  Discharge Medications: 1. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
2. diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) Capsule, Extended Release PO DAILY (Daily).
3. ethacrynic acid 25 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).
4. hydromorphone 2 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain.
